Hexarelin Peptide research-grade
Hexarelin Peptide
$32.00 $69.00Price range: $32.00 through $69.00 Select options

Hexarelin Peptide

Price range: $32.00 through $69.00

Research-grade Hexarelin Peptide for laboratory investigation. For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

Hexarelin Peptide research-grade

Overview

Hexarelin Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for Hexarelin Peptide

Work involving Hexarelin Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of Hexarelin Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source Hexarelin Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with Hexarelin Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using Hexarelin Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of Hexarelin Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 173 PubMed records. Displaying 10 per page.

  1. Mao Y et al. (2014). The cardiovascular action of hexarelin [PMID: 25278975]

    Laboratory literature summary: The cardiovascular action of hexarelin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Guan C et al. (2023). Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway [PMID: 37710348]

    Laboratory literature summary: Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Jiang B et al. (2022). Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype… [PMID: 34856183]

    Laboratory literature summary: Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Korbonits M et al. (1999). Hexarelin as a test of pituitary reserve in research subjects with pituitary disease [PMID: 10469018]

    Laboratory literature summary: Hexarelin as a test of pituitary reserve in research subjects with pituitary disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Mosa RM et al. (2015). Laboratory research record on Hexarelin [PMID: 25645463]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  6. Baser T et al. (2021). Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in… [PMID: 32893668]

    Laboratory literature summary: Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Giustina A et al. (1995). Hexarelin, a novel GHRP-6 analog, counteracts the inhibitory effect of hydrocortisone… [PMID: 7588427]

    Laboratory literature summary: Hexarelin, a novel GHRP-6 analog, counteracts the inhibitory effect of hydrocortisone on growth hormone secretion in acromegaly. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Filigheddu N et al. (2001). Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death [PMID: 11322493]

    Laboratory literature summary: Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Zambelli V et al. (2021). Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury [PMID: 34871336]

    Laboratory literature summary: Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  10. Rigamonti AE et al. (1999). Six-week investigation with hexarelin in young dogs: evaluation of the GH… [PMID: 10474131]

    Laboratory literature summary: Six-week investigation with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  11. Agbo E et al. (2019). Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy via the… [PMID: 31526442]

    Laboratory literature summary: Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy via the regulation of autophagy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  12. Cheng XL et al. (2019). Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling… [PMID: 31386895]

    Laboratory literature summary: Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE(-/-) mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  13. Agbo E et al. (2019). Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart… [PMID: 31091855]

    Laboratory literature summary: Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  14. Arosio M et al. (1998). Lack of effect of hexarelin on TRH-induced TSH response in normal adult man [PMID: 9624598]

    Laboratory literature summary: Lack of effect of hexarelin on TRH-induced TSH response in normal adult man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Deghenghi R (2008). Hexarelin: a multi-receptor peptide [PMID: 18787392]

    Laboratory literature summary: Hexarelin: a multi-receptor peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Rahim A et al. (1998). Does desensitization to hexarelin occur? [PMID: 10990150]

    Laboratory literature summary: Does desensitization to hexarelin occur?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Mao Y et al. (2013). Hexarelin investigation in research models ghrelin knockout mice after myocardial… [PMID: 23861368]

    Laboratory literature summary: Hexarelin investigation in research models ghrelin knockout mice after myocardial infarction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Meanti R et al. (2021). Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen… [PMID: 34066741]

    Laboratory literature summary: Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic Toxicity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  19. Massoud AF et al. (1997). Interaction of the growth hormone releasing peptide hexarelin with somatostatin [PMID: 9425393]

    Laboratory literature summary: Interaction of the growth hormone releasing peptide hexarelin with somatostatin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  20. Massoud AF et al. (1996). The effect of repeated administration of hexarelin, a growth hormone releasing… [PMID: 8762732]

    Laboratory literature summary: The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  21. Chow KBS (2026). Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection [PMID: 41766237]

    Laboratory literature summary: Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  22. Roumi M et al. (2000). Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats [PMID: 10611139]

    Laboratory literature summary: Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  23. Torsello A et al. (1997). Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult… [PMID: 9067986]

    Laboratory literature summary: Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  24. Coiro V et al. (2000). Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome [PMID: 10886488]

    Laboratory literature summary: Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  25. Xu X et al. (2007). Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat [PMID: 17766487]

    Laboratory literature summary: Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  26. Arvat E et al. (1994). Arginine and growth hormone-releasing hormone restore the blunted growth… [PMID: 7962341]

    Laboratory literature summary: Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  27. Mao Y et al. (2014). One exposure level of oral hexarelin protects chronic cardiac function after… [PMID: 24747279]

    Laboratory literature summary: One exposure level of oral hexarelin protects chronic cardiac function after myocardial infarction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  28. Rahim A et al. (1998). Growth hormone status during long-term hexarelin research protocol [PMID: 9589671]

    Laboratory literature summary: Growth hormone status during long-term hexarelin research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  29. Pettersson I et al. (2002). Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2… [PMID: 12379504]

    Laboratory literature summary: Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  30. Massoud AF et al. (1995). Hexarelin induced growth hormone release is influenced by exogenous growth hormone [PMID: 8548947]

    Laboratory literature summary: Hexarelin induced growth hormone release is influenced by exogenous growth hormone. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  31. Meanti R et al. (2023). Protective Effects of Hexarelin and JMV2894 in a research subjects Neuroblastoma Cell… [PMID: 36674509]

    Laboratory literature summary: Protective Effects of Hexarelin and JMV2894 in a research subjects Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  32. Zhang X et al. (2018). Laboratory research record on Hexarelin [PMID: 29446246]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  33. Ciccarelli E et al. (1996). Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin… [PMID: 8706295]

    Laboratory literature summary: Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  34. Locatelli V et al. (1999). Growth hormone-independent cardioprotective effects of hexarelin in the rat [PMID: 10465272]

    Laboratory literature summary: Growth hormone-independent cardioprotective effects of hexarelin in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  35. Pang J et al. (2010). Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat [PMID: 19931584]

    Laboratory literature summary: Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  36. Conley LK et al. (1995). Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and… [PMID: 7731497]

    Laboratory literature summary: Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  37. Rahim A et al. (1999). The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin [PMID: 10341859]

    Laboratory literature summary: The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  38. McDonald H et al. (2018). Hexarelin investigation preserves myocardial function and reduces cardiac fibrosis in… [PMID: 29756411]

    Laboratory literature summary: Hexarelin investigation preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  39. Korbonits M et al. (1999). The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal… [PMID: 10404825]

    Laboratory literature summary: The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  40. Pang JJ et al. (2004). Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro [PMID: 14615277]

    Laboratory literature summary: Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  41. Micic D et al. (1996). The sequential administration of growth hormone-releasing hormone followed 120 minutes… [PMID: 8977750]

    Laboratory literature summary: The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  42. Xu X et al. (2012). Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously… [PMID: 22842067]

    Laboratory literature summary: Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  43. Broglio F et al. (2002). Effects of acute hexarelin administration on cardiac performance in research subjects… [PMID: 12144941]

    Laboratory literature summary: Effects of acute hexarelin administration on cardiac performance in research subjects with coronary artery disease during by-pass surgery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  44. Arvat E et al. (1995). Modulation of growth hormone-releasing activity of hexarelin in man [PMID: 7731498]

    Laboratory literature summary: Modulation of growth hormone-releasing activity of hexarelin in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  45. Bresciani E et al. (2008). Feeding behavior during long-term hexarelin administration in young and old rats [PMID: 18787385]

    Laboratory literature summary: Feeding behavior during long-term hexarelin administration in young and old rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  46. Biagini G et al. (2011). Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status… [PMID: 21914437]

    Laboratory literature summary: Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  47. Giustina A et al. (1997). Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a… [PMID: 9250581]

    Laboratory literature summary: Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  48. Sartorio A et al. (1995). GH responsiveness to repeated GHRH or hexarelin administration in normal adults [PMID: 8719303]

    Laboratory literature summary: GH responsiveness to repeated GHRH or hexarelin administration in normal adults. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  49. Rahim A et al. (1998). The effect of body composition on hexarelin-induced growth hormone release in normal… [PMID: 10197083]

    Laboratory literature summary: The effect of body composition on hexarelin-induced growth hormone release in normal elderly subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  50. Sirago G et al. (2017). Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from… [PMID: 29026190]

    Laboratory literature summary: Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  51. Waddingham MT et al. (2021). Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin… [PMID: 35126171]

    Laboratory literature summary: Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  52. Demers A et al. (2008). Hexarelin Signaling to PPARgamma in Metabolic Diseases [PMID: 18288286]

    Laboratory literature summary: Hexarelin Signaling to PPARgamma in Metabolic Diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  53. Mosa R et al. (2017). Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in… [PMID: 28977588]

    Laboratory literature summary: Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant research models MKR Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  54. Rossoni G et al. (2000). Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from… [PMID: 10887041]

    Laboratory literature summary: Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  55. Maccario M et al. (1995). Metabolic modulation of the growth hormone-releasing activity of hexarelin in man [PMID: 7854159]

    Laboratory literature summary: Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  56. Ghigo E et al. (1994). Laboratory research record on Hexarelin [PMID: 8126144]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  57. Popovic V et al. (1997). Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH… [PMID: 9231048]

    Laboratory literature summary: Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in research subjects with anorexia nervosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  58. Westberg C et al. (2001). Hexarelin–evaluation of factors influencing oral bioavailability and ways to improve… [PMID: 11578108]

    Laboratory literature summary: Hexarelin–evaluation of factors influencing oral bioavailability and ways to improve absorption. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  59. McDonald H et al. (2020). Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and… [PMID: 32403043]

    Laboratory literature summary: Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  60. Orkin RD et al. (2003). Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro [PMID: 14669829]

    Laboratory literature summary: Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  61. Massoud AF et al. (1996). Hexarelin-induced growth hormone, cortisol, and prolactin release: a exposure… [PMID: 8954038]

    Laboratory literature summary: Hexarelin-induced growth hormone, cortisol, and prolactin release: a exposure level-response study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  62. De Gennaro-Colonna V et al. (2000). Laboratory research record on Hexarelin [PMID: 10974647]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  63. Huang J et al. (2017). The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo… [PMID: 28321024]

    Laboratory literature summary: The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  64. Cella SG et al. (1995). Hexarelin, a potent GHRP analogue: interactions with GHRH and clonidine in young and… [PMID: 7716078]

    Laboratory literature summary: Hexarelin, a potent GHRP analogue: interactions with GHRH and clonidine in young and aged dogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  65. Zhao Y et al. (2016). Hexarelin Protects Rodent Pancreatic Β-Cells Function from Cytotoxic Effects of… [PMID: 26918825]

    Laboratory literature summary: Hexarelin Protects Rodent Pancreatic Β-Cells Function from Cytotoxic Effects of Streptozotocin Involving Mitochondrial Signalling…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  66. Conley LK et al. (2000). The effects of a continuous infusion of hexarelin on pulsatile growth hormone release,… [PMID: 11081146]

    Laboratory literature summary: The effects of a continuous infusion of hexarelin on pulsatile growth hormone release, growth axis and galanin gene expression and on…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  67. Bedendi I et al. (2001). Role of endothelial cells in modulation of contractility induced by hexarelin in rat… [PMID: 11669462]

    Laboratory literature summary: Role of endothelial cells in modulation of contractility induced by hexarelin in rat ventricle. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  68. Roumi M et al. (2001). Permeability of the peptidic GH secretagogues hexarelin and EP 51389, across rat jejunum [PMID: 11445244]

    Laboratory literature summary: Permeability of the peptidic GH secretagogues hexarelin and EP 51389, across rat jejunum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  69. Tivesten A et al. (2000). The growth hormone secretagogue hexarelin improves cardiac function in rats after… [PMID: 10614623]

    Laboratory literature summary: The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  70. Loche S et al. (1997). The growth hormone response to hexarelin in children: reproducibility and effect of… [PMID: 9062497]

    Laboratory literature summary: The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  71. Frieboes RM et al. (2004). Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol… [PMID: 15177700]

    Laboratory literature summary: Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  72. Deghenghi R et al. (1994). GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant… [PMID: 7910650]

    Laboratory literature summary: GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  73. Liu Q et al. (2000). Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the… [PMID: 12845719]

    Laboratory literature summary: Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the secretion of GH by cultured research subjects pituitary…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  74. Torsello A et al. (2001). Hexarelin, but not growth hormone, protects heart from damage induced in vitro by… [PMID: 11322492]

    Laboratory literature summary: Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  75. Laron Z et al. (1995). Intranasal administration of the GHRP hexarelin accelerates growth in short children [PMID: 8548949]

    Laboratory literature summary: Intranasal administration of the GHRP hexarelin accelerates growth in short children. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  76. Imbimbo BP et al. (1994). Growth hormone-releasing activity of hexarelin in research subjects. A exposure… [PMID: 7957536]

    Laboratory literature summary: Growth hormone-releasing activity of hexarelin in research subjects. A exposure level-response study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  77. Roumi M et al. (1995). Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its… [PMID: 8545255]

    Laboratory literature summary: Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its pharmacokinetic studies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  78. Sibilia V et al. (2004). Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat [PMID: 15572206]

    Laboratory literature summary: Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  79. Cappa M et al. (1998). The growth hormone response to hexarelin in research subjects with Prader-Willi syndrome [PMID: 9801990]

    Laboratory literature summary: The growth hormone response to hexarelin in research subjects with Prader-Willi syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  80. Bisi G et al. (1999). Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic… [PMID: 10342360]

    Laboratory literature summary: Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  81. Conley LK et al. (1998). Effects of repeated doses and continuous infusions of the growth hormone-releasing… [PMID: 9846166]

    Laboratory literature summary: Effects of repeated doses and continuous infusions of the growth hormone-releasing peptide hexarelin in conscious research models rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  82. Maghnie M et al. (1998). The growth hormone response to hexarelin in research subjects with different… [PMID: 9814463]

    Laboratory literature summary: The growth hormone response to hexarelin in research subjects with different hypothalamic-pituitary abnormalities. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  83. Zhang X et al. (2018). Laboratory research record on Hexarelin [PMID: 30297647]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  84. Giustina A et al. (1996). Laboratory research record on Hexarelin [PMID: 8799695]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  85. Bisi G et al. (1999). Cardiac effects of hexarelin in hypopituitary adults [PMID: 10528131]

    Laboratory literature summary: Cardiac effects of hexarelin in hypopituitary adults. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  86. Dahlgren D et al. (2021). Effect of paracellular permeation enhancers on intestinal permeability of two peptide… [PMID: 34221875]

    Laboratory literature summary: Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  87. Melis MR et al. (2001). Penile erection induced by EP 80661 and other hexarelin peptide analogues: involvement… [PMID: 11164389]

    Laboratory literature summary: Penile erection induced by EP 80661 and other hexarelin peptide analogues: involvement of paraventricular nitric oxide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  88. Loche S et al. (1997). Acute administration of hexarelin stimulates GH secretion during day and night in… [PMID: 9156035]

    Laboratory literature summary: Acute administration of hexarelin stimulates GH secretion during day and night in normal research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  89. Benso A et al. (2003). Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin… [PMID: 14594107]

    Laboratory literature summary: Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  90. Arvat E et al. (1996). Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of… [PMID: 8851688]

    Laboratory literature summary: Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  91. Loche S et al. (1995). The effect of hexarelin on growth hormone (GH) secretion in research subjects with GH… [PMID: 7673411]

    Laboratory literature summary: The effect of hexarelin on growth hormone (GH) secretion in research subjects with GH deficiency. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  92. Torsello A et al. (1996). Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat [PMID: 8921832]

    Laboratory literature summary: Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  93. Puechagut PB et al. (2012). Reproductive performance and reproductive-biology research in research models and… [PMID: 22401277]

    Laboratory literature summary: Reproductive performance and reproductive-biology research in research models and research models adult mice chronically studied with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  94. Rossoni G et al. (1998). Protectant activity of hexarelin or growth hormone against postischemic ventricular… [PMID: 9700988]

    Laboratory literature summary: Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  95. Arvat E et al. (1999). Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of… [PMID: 10195374]

    Laboratory literature summary: Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  96. Bresciani E et al. (2004). Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a… [PMID: 15361691]

    Laboratory literature summary: Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  97. Dahlgren D et al. (2020). The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal… [PMID: 31991924]

    Laboratory literature summary: The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  98. Laron Z et al. (1994). Growth hormone releasing activity by intranasal administration of a synthetic… [PMID: 7955465]

    Laboratory literature summary: Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  99. Tolis G et al. (1997). Growth hormone release by the novel GH releasing peptide hexarelin in research… [PMID: 9364340]

    Laboratory literature summary: Growth hormone release by the novel GH releasing peptide hexarelin in research subjects with homozygous beta-thalassemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  100. Bellone J et al. (1998). Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in… [PMID: 9801989]

    Laboratory literature summary: Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  101. Yu H et al. (2009). Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin… [PMID: 19501141]

    Laboratory literature summary: Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  102. Barlind A et al. (2010). The growth hormone secretagogue hexarelin increases cell proliferation in neurogenic… [PMID: 19800825]

    Laboratory literature summary: The growth hormone secretagogue hexarelin increases cell proliferation in neurogenic regions of the mouse hippocampus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  103. Arvat E et al. (1999). Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal… [PMID: 10516483]

    Laboratory literature summary: Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  104. Sibilia V et al. (2002). Bone effects of hexarelin, a GH-releasing peptide, in research models rats: influence… [PMID: 12039707]

    Laboratory literature summary: Bone effects of hexarelin, a GH-releasing peptide, in research models rats: influence of estrogen-pathway markers-pathway markers milieu. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  105. Korbonits M et al. (1995). The effect of an opiate antagonist on the hormonal changes induced by hexarelin [PMID: 7586608]

    Laboratory literature summary: The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  106. Bartolotta E et al. (1997). The GH-releasing effect of Hexarelin, a synthetic hexapeptide, in newborns is lower… [PMID: 9401905]

    Laboratory literature summary: The GH-releasing effect of Hexarelin, a synthetic hexapeptide, in newborns is lower than in young adults. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  107. Torsello A et al. (1998). Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving… [PMID: 9851578]

    Laboratory literature summary: Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  108. Semenistaya E et al. (2015). Determination of growth hormone releasing peptides metabolites in research subjects… [PMID: 25869809]

    Laboratory literature summary: Determination of growth hormone releasing peptides metabolites in research subjects urine after nasal administration of GHRP-1, GHRP-2,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  109. Klinger B et al. (1996). Desensitization from long-term intranasal investigation with hexarelin does not… [PMID: 8766941]

    Laboratory literature summary: Desensitization from long-term intranasal investigation with hexarelin does not interfere with the biological effects of this growth…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  110. Arvat E et al. (2001). Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in… [PMID: 11238504]

    Laboratory literature summary: Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in research subjects: comparison and interactions with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  111. Benso A et al. (2007). D-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin… [PMID: 17112585]

    Laboratory literature summary: d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  112. Sibilia V et al. (1999). Hexarelin, a growth hormone – releasing peptide, counteracts bone loss in… [PMID: 10512687]

    Laboratory literature summary: Hexarelin, a growth hormone – releasing peptide, counteracts bone loss in gonadectomized research models rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  113. Sibilia V et al. (2000). The influence of sex and gonadectomy on the growth hormone and corticosterone response… [PMID: 11191647]

    Laboratory literature summary: The influence of sex and gonadectomy on the growth hormone and corticosterone response to hexarelin in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  114. Luque EM et al. (2010). Effects of hexarelin (a ghrelin analogue) on fertilisation and the pre- and postnatal… [PMID: 20591327]

    Laboratory literature summary: Effects of hexarelin (a ghrelin analogue) on fertilisation and the pre- and postnatal development of mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  115. Cella SG et al. (1996). Sixteen weeks of hexarelin research protocol in aged dogs: effects on the somatotropic… [PMID: 8914494]

    Laboratory literature summary: Sixteen weeks of hexarelin research protocol in aged dogs: effects on the somatotropic axis, muscle morphology, and bone metabolism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  116. Gasperi M et al. (1999). Low exposure level hexarelin and growth hormone (GH)-releasing hormone as a analytical… [PMID: 10443652]

    Laboratory literature summary: Low exposure level hexarelin and growth hormone (GH)-releasing hormone as a analytical assessment tool for the analytical assessment of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  117. Liu Q et al. (1999). Effects of the novel GH secretogogue, hexarelin on GH secretion and… [PMID: 12840903]

    Laboratory literature summary: Effects of the novel GH secretogogue, hexarelin on GH secretion and phosphatidylinositol hydrolysis by research subjects pituitary…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  118. De Gennaro Colonna V et al. (1997). Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against… [PMID: 9534309]

    Laboratory literature summary: Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against cardiovascular damage in rats with isolated growth…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  119. Prodam F et al. (2008). Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not… [PMID: 18061663]

    Laboratory literature summary: Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  120. Ghigo E et al. (1996). Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide,… [PMID: 8921821]

    Laboratory literature summary: Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  121. Arvat E et al. (2000). Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph… [PMID: 11078983]

    Laboratory literature summary: Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  122. Bellone J et al. (1995). Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before… [PMID: 7714074]

    Laboratory literature summary: Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  123. Maccario M et al. (2002). Laboratory research record on Hexarelin [PMID: 11888836]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  124. Roumi M et al. (1997). Hepatic extraction of hexarelin, a new peptidic GH secretagogue, in the isolated… [PMID: 9279881]

    Laboratory literature summary: Hepatic extraction of hexarelin, a new peptidic GH secretagogue, in the isolated perfused rat liver. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  125. Arvat E et al. (1997). Effects of histaminergic antagonists on the GH-releasing activity of GHRH or… [PMID: 9186817]

    Laboratory literature summary: Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  126. Arvat E et al. (1997). Mechanisms underlying the negative growth hormone (GH) autofeedback on the… [PMID: 9005975]

    Laboratory literature summary: Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  127. Grottoli S et al. (1996). Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the… [PMID: 9025712]

    Laboratory literature summary: Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in metabolic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  128. Rigamonti AE et al. (1999). Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young… [PMID: 10024078]

    Laboratory literature summary: Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young and old dogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  129. Imazio M et al. (2002). GH-independent cardiotropic activities of hexarelin in research subjects with severe… [PMID: 11959048]

    Laboratory literature summary: GH-independent cardiotropic activities of hexarelin in research subjects with severe left ventricular dysfunction due to dilated and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  130. Poppi L et al. (2002). Growth hormone secretagogue (GHS) analogue, hexarelin stimulates GH from peripheral… [PMID: 12397533]

    Laboratory literature summary: Growth hormone secretagogue (GHS) analogue, hexarelin stimulates GH from peripheral lymphocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  131. Cattaneo L et al. (1997). Effect of long-term administration of Hexarelin on the somatotrophic axis in aged rats [PMID: 9368914]

    Laboratory literature summary: Effect of long-term administration of Hexarelin on the somatotrophic axis in aged rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  132. Grottoli S et al. (1999). Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity… [PMID: 11081154]

    Laboratory literature summary: Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  133. Brywe KG et al. (2005). Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters… [PMID: 16081643]

    Laboratory literature summary: Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  134. Gianotti L et al. (2001). Recombinant research subjects IGF-I does not modify the ACTH and cortisol responses to… [PMID: 11263473]

    Laboratory literature summary: Recombinant research subjects IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  135. Arvat E et al. (1997). Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with… [PMID: 9430449]

    Laboratory literature summary: Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  136. Berti F et al. (1998). Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth… [PMID: 10990152]

    Laboratory literature summary: Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  137. Arvat E et al. (1997). Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH,… [PMID: 9285939]

    Laboratory literature summary: Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  138. Torsello A et al. (2000). Laboratory research record on Hexarelin [PMID: 11146415]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  139. Rossoni G et al. (1999). Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic… [PMID: 10471007]

    Laboratory literature summary: Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  140. Arvat E et al. (1997). Low hexarelin exposure level and pyridostigmine have additive effect and potentiate to… [PMID: 9404449]

    Laboratory literature summary: Low hexarelin exposure level and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  141. Ramunni J et al. (1999). Young adults with Down's syndrome show increased corticotrope responsiveness to hCRH… [PMID: 10727046]

    Laboratory literature summary: Young adults with Down's syndrome show increased corticotrope responsiveness to hCRH or hexarelin, a peptidyl GH secretagogue. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  142. Guzzaloni G et al. (1999). Hexarelin-induced growth hormone response in short stature. Comparison with growth… [PMID: 10401710]

    Laboratory literature summary: Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  143. Foppiani L et al. (1998). Dopaminergic modulation of hexarelin-induced GH and PRL secretion in hyperprolactinemia [PMID: 9586422]

    Laboratory literature summary: Dopaminergic modulation of hexarelin-induced GH and PRL secretion in hyperprolactinemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  144. Mainardi GL et al. (2002). Effects of interleukin-1-beta, interleukin-6 and oncology research models necrosis… [PMID: 12324716]

    Laboratory literature summary: Effects of interleukin-1-beta, interleukin-6 and oncology research models necrosis factor-alpha, alone or in association with hexarelin…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  145. Arvat E et al. (1999). Effects of the combined administration of hexarelin, a synthetic peptidyl GH… [PMID: 10090133]

    Laboratory literature summary: Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  146. De Gennaro Colonna V et al. (1997). Cardiac ischemia and impairment of vascular endothelium function in hearts from growth… [PMID: 9369349]

    Laboratory literature summary: Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  147. Ghigo E et al. (1999). Effects of recombinant research subjects insulin-like growth factor I administration… [PMID: 9920097]

    Laboratory literature summary: Effects of recombinant research subjects insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  148. Melis MR et al. (2000). EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats [PMID: 10980272]

    Laboratory literature summary: EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  149. Grottoli S et al. (2000). Laboratory research record on Hexarelin [PMID: 10997633]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  150. De Marinis L et al. (2000). Role of food intake in the modulation of hexarelin-induced growth hormone release in… [PMID: 10824712]

    Laboratory literature summary: Role of food intake in the modulation of hexarelin-induced growth hormone release in normal research subjects subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  151. Arvat E et al. (1997). The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide,… [PMID: 9437229]

    Laboratory literature summary: The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  152. Fagerholm U et al. (1998). The effect of a drug-delivery system consisting of soybean phosphatidyl choline and… [PMID: 9643439]

    Laboratory literature summary: The effect of a drug-delivery system consisting of soybean phosphatidyl choline and medium-chain monoacylglycerol on the intestinal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  153. Desaphy JF et al. (1998). Partial recovery of skeletal muscle sodium channel properties in aged rats chronically… [PMID: 9694949]

    Laboratory literature summary: Partial recovery of skeletal muscle sodium channel properties in aged rats chronically studied with growth hormone or the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  154. Giordano R et al. (1999). Corticotroph and adrenal responsiveness to hCRH, hexarelin and ACTH in young and… [PMID: 10727060]

    Laboratory literature summary: Corticotroph and adrenal responsiveness to hCRH, hexarelin and ACTH in young and elderly subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  155. Maheshwari HG et al. (1999). Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin… [PMID: 10084578]

    Laboratory literature summary: Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in research subjects with GH-releasing hormone…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  156. Grottoli S et al. (1997). Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine… [PMID: 9438917]

    Laboratory literature summary: Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  157. Giusti M et al. (1997). Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling research… [PMID: 9258804]

    Laboratory literature summary: Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling research subjects but not in anorexia nervosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  158. Arvat E et al. (1998). Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in research subjects… [PMID: 9851753]

    Laboratory literature summary: Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in research subjects with Cushing's disease bearing a pituitary…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  159. Succu S et al. (2003). Activation of GABAA and opioid receptors reduce penile erection induced by hexarelin… [PMID: 14643856]

    Laboratory literature summary: Activation of GABAA and opioid receptors reduce penile erection induced by hexarelin peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  160. Loche S et al. (1995). Laboratory research record on Hexarelin [PMID: 7852535]

    PubMed laboratory record discussing Hexarelin in a research context. Review the full methods and limitations on PubMed; research use only.

  161. Cappa M et al. (1995). Exogenous growth hormone administration does not inhibit the growth hormone response… [PMID: 8787952]

    Laboratory literature summary: Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  162. Ghigo E et al. (1997). Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth… [PMID: 9253314]

    Laboratory literature summary: Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  163. Giustina A et al. (1995). Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel… [PMID: 7561633]

    Laboratory literature summary: Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  164. Jenkins RC et al. (1999). The effects of exposure level, nutrition, and age on hexarelin-induced anterior… [PMID: 10199757]

    Laboratory literature summary: The effects of exposure level, nutrition, and age on hexarelin-induced anterior pituitary hormone secretion in adult research subjects…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  165. Arvat E et al. (1998). Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic… [PMID: 9854683]

    Laboratory literature summary: Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  166. Arvat E et al. (1997). Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin,… [PMID: 9186268]

    Laboratory literature summary: Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  167. Guzzaloni G et al. (2000). Differences of hexarelin-induced prolactin and cortisol responses between prepubertal… [PMID: 10968479]

    Laboratory literature summary: Differences of hexarelin-induced prolactin and cortisol responses between prepubertal and early pubertal short children and lack of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  168. Arvat E et al. (1998). Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect… [PMID: 9641612]

    Laboratory literature summary: Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  169. Rigamonti AE et al. (1998). Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and… [PMID: 9518881]

    Laboratory literature summary: Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  170. Settembrini B et al. (1998). Growth Hormone (GH) but not IGF-I-Secretion is Stimulated in Aged Rats by Chronic… [PMID: 10407366]

    Laboratory literature summary: Growth Hormone (GH) but not IGF-I-Secretion is Stimulated in Aged Rats by Chronic Hexarelin and GHRP-6 administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  171. Bellone J et al. (2000). The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the… [PMID: 10803472]

    Laboratory literature summary: The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  172. Frenkel J et al. (1995). Short term effect of intranasal administration of hexarelin–a synthetic growth… [PMID: 7584696]

    Laboratory literature summary: Short term effect of intranasal administration of hexarelin–a synthetic growth hormone-releasing peptide. Preliminary communication. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  173. Guzzaloni G et al. (1998). Growth hormone response to hexarelin, growth hormone-releasing hormone plus… [PMID: 10361807]

    Laboratory literature summary: Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen-pathway markers-pathway markers in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in
Size: No selection

2 mg, 5 mg, 10 mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is Hexarelin peptide?

Hexarelin is a synthetic growth hormone releasing peptide (GHRP) that interacts with ghrelin receptors. It is studied in research laboratories for its role in hormone signaling and receptor activity.

What is Hexarelin used for in research?

Hexarelin is used in research laboratories to investigate growth hormone release, receptor binding, and endocrine signaling pathways. It is not approved for human use.

Is Hexarelin Peptide approved or intended for human use?

No. Hexarelin is strictly intended for research purposes only and is not approved by the FDA for human use.

Is Hexarelin Peptide FDA-approved for medical or clinical use?

No. Hexarelin is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is Hexarelin supplied?

Hexarelin is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should Hexarelin be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for Hexarelin?

Hexarelin is available in multiple vial sizes (e.g., 5mg, 10mg).

Is Hexarelin Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is Hexarelin shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/

How can I verify Hexarelin purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://www.nationwidepeptides.com/coa/